2021 - Participating Startup Companies
Adjuvant Genomics combines genetic analysis and computational biology that can predetermine the success of adjuvant chemotherapy in Non-Small-Cell Lung Cancer patients.
~50% of NSCLC patients fail chemotherapy. This results in undue burden on the health care system and negative patient outcomes due to the effects of chemo. Adjuvant aims to prevent any patient that will not benefit from chemotherapy from receiving it.
A simple diagnostic test, sent through our proprietary amplification and screening protocol, and combined with artificial intelligence algorithms, provides the answer.